Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.88
-0.01 (-0.02%)
At close: Jul 9, 2026, 4:00 PM EDT
49.19
+0.31 (0.63%)
Pre-market: Jul 10, 2026, 7:25 AM EDT

Novo Nordisk Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Novo Nordisk stock has a consensus rating of "Buy" and an average price target of $47.91. The average 1-year stock price forecast is 1.98% lower than the current stock price, while the lowest is $39.53 (-19.13%) and the highest is $62.96 (+28.81%).

Price Target: $47.91 (-1.98%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$39.53$47.91$46.16$62.96
Change-19.13%-1.98%-5.56%+28.81%

Analyst Ratings

The average analyst rating for Novo Nordisk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy664444
Buy011110
Hold5599910
Sell000000
Strong Sell210000
Total131314141414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Hold
Maintains
$42
HoldMaintains$42-14.08%Jun 29, 2026
BMO Capital
BMO Capital
Hold
Maintains
$45
HoldMaintains$45-7.94%Jun 22, 2026
Goldman Sachs
Goldman Sachs
Hold
Maintains
$41$47
HoldMaintains$41$47-3.85%Jun 3, 2026
Argus Research
Argus Research
Hold
Maintains
n/a
HoldMaintainsn/an/aMar 20, 2026
Berenberg Bank
Berenberg Bank
Buy
Maintains
$57$47
BuyMaintains$57$47-3.85%Mar 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
293.19B
from 309.06B
Decreased by -5.13%
Revenue Next Year
298.91B
from 293.19B
Increased by 1.95%
EPS This Year
20.99
from 23.03
Decreased by -8.85%
EPS Next Year
21.45
from 20.99
Increased by 2.16%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
140.80B176.95B232.26B290.40B309.06B293.19B
Revenue Growth
10.91%25.68%31.26%25.03%6.43%-5.13%
Gross Profit
117.14B148.53B196.94B246.84B254.69B239.77B
Gross Margin
83.20%83.94%84.79%85.00%82.41%81.78%
Operating Income
59.22B75.62B104.70B138.90B140.62B121.78B
Net Income
47.76B55.53B83.68B100.99B102.43B98.59B
EPS
----23.0320.99
EPS Growth
----1.77%-8.85%
Forward PE
-----15.22
Dividend / Share
5.206.209.4011.4011.7011.35
Dividend Growth
-19.23%51.61%21.28%2.63%-2.97%
Free Cash Flow
43.90B57.50B54.55B60.57B376.88M46.25B
No. Analysts
-----28
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.

Revenue Forecast

Revenue202620272028
High321.4B
Avg293.2B
Low272.7B

Revenue Growth

Revenue Growth202620272028
High
4.0%
Avg
-5.1%
Low
-11.8%

EPS Forecast

EPS202620272028
High24.40
Avg20.99
Low18.59

EPS Growth

EPS Growth202620272028
High
5.9%
Avg
-8.8%
Low
-19.3%